Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pa Degraeff"'
Publikováno v:
DRUGS, 51(4), 507-514. ADIS INT LTD
This article discusses various aspects of cholesterol-lowering therapy using the HMG-CoA reductase inhibitor simvastatin in the light of the large Scandinavian Simvastatin Survival Study (4S). In 4S, patients with proven coronary heart disease (CHD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347afaeaa083ba4c806fff5d5c5dfc54
https://pubmed.ncbi.nlm.nih.gov/8706591
https://pubmed.ncbi.nlm.nih.gov/8706591
Autor:
Harry Wesseling, Pa Degraeff, Hans L. Hillege, Ki Lie, Wh Vangilst, Saj Vandenbroek, A Vanbruggen
Publikováno v:
Journal of cardiovascular pharmacology. 18(4)
The acute hemodynamic, hormonal, and pharmacokinetic responses to the oral angiotensin-converting enzyme (ACE) inhibitor spirapril were studied in 15 patients with moderate to severe congestive heart failure in a baseline controlled dose-ranging stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16b02bc63fa603002fd02f97ac7687d
https://pubmed.ncbi.nlm.nih.gov/1724540
https://pubmed.ncbi.nlm.nih.gov/1724540
Publikováno v:
European journal of pharmacology. 100(1)
Captopril was perfused through isolated rat hearts; its effects after local ischemia and reperfusion were assessed. Upon reperfusion all untreated (10 out of 10) but only 4 (out of 10) captopril-treated (80 micrograms/ml) hearts fibrillated (P less t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115532e25e684548ed76c3328f350327
https://pubmed.ncbi.nlm.nih.gov/6373306
https://pubmed.ncbi.nlm.nih.gov/6373306
Publikováno v:
Nephron, 40(2), 155-160. KARGER
University of Groningen
University of Groningen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46cb70440fee096b214c5a9d0beaa738
https://research.rug.nl/en/publications/58d00891-9ca4-4f4e-8d99-fd0b255bde8f
https://research.rug.nl/en/publications/58d00891-9ca4-4f4e-8d99-fd0b255bde8f
Publikováno v:
Journal of Molecular and Cellular Cardiology. 18:68-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::280c1c2441517b284e84c41cd5e1467f
https://doi.org/10.1016/s0022-2828(86)80682-4
https://doi.org/10.1016/s0022-2828(86)80682-4
Autor:
deGraeff PA; Department of Pharmacology/Clinical Pharmacology, University of Groningen, The Netherlands., deLangen CD, van Gilst WH, Bel K, Scholtens E, Kingma JH, Wesseling H
Publikováno v:
The American journal of medicine [Am J Med] 1988 Mar 11; Vol. 84 (3A), pp. 67-74.